Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-26 @ 2:48 AM
NCT ID:
NCT01372202
Group ID:
EG001
Title:
Arm B
Description:
Oxaliplatin with 5-Fluorouracil along with Radiotherapy and followed by Esophagectomy
Cisplatin: Paclitaxel and cisplatin:
* Paclitaxel 50 mg/m² (1 hr) days 1, 8, 15, 22, 29.
* Cisplatin 30 mg/m² days 1, 8, 15, 22, 29.
Cisplatin and 5-fluorouracil:
* 5-Fluorouracil 1000 mg/m2 per day over 24 hours days 1- 4 and 29 - 32.
* Cisplatin 75 mg/m² days 1, 29.
Oxaliplatin: Oxaliplatin 85 mg/m2 days 1, 15, 29.
5-Fu: Oxaliplatin \& 5-fu:
* Oxaliplatin 85 mg/m2 days 1, 15, 29.
* 5-Fu 180 mg/m2 prolonged infusion day 1 of radiation \& completing on the final day of radiation
Cisplatin/5-fluorouracil:
* 5-Fu 1000 mg/m2 per day over 24 hours days 1-4 and 29-32.
* Cisplatin 75 mg/m² days 1, 29.
Radiotherapy: Treated 5 days/week at 1.8 Gy/day to a total dose of 45Gy.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
9
Other Number Affected:
1
Other Number At Risk:
9
Study:
NCT01372202
Results Section:
NCT01372202
Adverse Events Module:
NCT01372202